$0.18 EPS Expected for Medidata Solutions, Inc. (MDSO)

January 13, 2018 - By Adrian Mccoy

 $0.18 EPS Expected for Medidata Solutions, Inc. (MDSO)
Investors sentiment increased to 1.23 in 2017 Q3. Its up 0.06, from 1.17 in 2017Q2. It improved, as 38 investors sold Medidata Solutions, Inc. shares while 60 reduced holdings. 33 funds opened positions while 88 raised stakes. 59.30 million shares or 4.96% more from 56.50 million shares in 2017Q2 were reported.
143,797 were reported by Strs Ohio. Marshall Wace Limited Liability Partnership holds 16,271 shares or 0.06% of its portfolio. Spectrum Group Incorporated holds 12 shares. 1.15M were reported by Canada Pension Plan Investment Board. Louisiana State Employees Retirement System accumulated 0.06% or 15,600 shares. The Pennsylvania-based Vanguard has invested 0.02% in Medidata Solutions, Inc. (NASDAQ:MDSO). Weaver C Barksdale And Assocs, a Tennessee-based fund reported 37 shares. Stephens Management Grp Limited Liability holds 854,600 shares or 1.54% of its portfolio. Brown Cap Management Limited Com stated it has 5.45M shares or 5.17% of all its holdings. Brinker Capital holds 0.03% or 9,181 shares in its portfolio. Hsbc Holdings Public Limited has 0% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 3,327 shares. 302,700 were accumulated by Ameriprise Finance. Eagle Asset Inc has invested 0.38% in Medidata Solutions, Inc. (NASDAQ:MDSO). Moreover, Arizona State Retirement Systems has 0.03% invested in Medidata Solutions, Inc. (NASDAQ:MDSO). Aperio Gru Limited Liability accumulated 0.01% or 12,848 shares.

Since August 15, 2017, it had 0 insider purchases, and 2 insider sales for $504,550 activity. 5,000 shares were sold by Capone Michael L, worth $372,650 on Tuesday, August 15.

Analysts expect Medidata Solutions, Inc. (NASDAQ:MDSO) to report $0.18 EPS on February, 8.They anticipate $0.05 EPS change or 21.74 % from last quarter’s $0.23 EPS. MDSO’s profit would be $10.53M giving it 92.92 P/E if the $0.18 EPS is correct. After having $0.22 EPS previously, Medidata Solutions, Inc.’s analysts see -18.18 % EPS growth. The stock increased 1.61% or $1.06 during the last trading session, reaching $66.9. About 423,310 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 68.37% since January 13, 2017 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. has $92.0 highest and $35 lowest target. $76.50’s average target is 14.35% above currents $66.9 stock price. Medidata Solutions Inc. had 38 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Market Perform” rating on Thursday, July 21 by Wells Fargo. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Hold” rating by Jefferies on Monday, August 21. The rating was upgraded by Suntrust Robinson to “Buy” on Friday, February 10. KeyBanc Capital Markets initiated the stock with “Overweight” rating in Wednesday, September 9 report. The stock has “Hold” rating by Jefferies on Tuesday, July 18. The stock has “Hold” rating by Jefferies on Thursday, September 28. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Needham on Monday, October 23. The firm earned “Buy” rating on Friday, February 10 by SunTrust. Wells Fargo upgraded the stock to “Buy” rating in Friday, December 1 report. The stock has “Buy” rating by Deutsche Bank on Friday, December 8.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $3.91 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 95.71 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

Another recent and important Medidata Solutions, Inc. (NASDAQ:MDSO) news was published by Seekingalpha.com which published an article titled: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q3 2017 Results – Earnings Call …” on October 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.